Industry-supported investigator-initiated trials present unique contracting challenges that often differ from traditional sponsor-led studies. This session will examine key IIT agreement provisions, including regulatory responsibility, funding, indemnification, subject injury, intellectual property, publication rights, and data ownership. Speakers will discuss common negotiation challenges and practical approaches for balancing investigator independence with appropriate risk allocation among all parties.